Neurology Technology Companies
-
Technologybased in Macedonia, OHIO (USA)
Indego has been developed in close coordination with clinicians and patients. Although the benefits of Indego hold great promise for its use in therapy and at home, Parker is committed to providing the most usable and effective exoskeleton device, ...
Indego - Exoskeleton
The Indego® Therapy exoskeleton offers clinicians the ability to provide highly individualized gait therapy, custom-tailored for spinal cord injury and stroke with a single adjustable size device. Rapidly adjustable hardware and customizable ...
CONTACT SUPPLIER -
Technologybased in Lexington, MASSACHUSETTS (USA)
At Dicerna, we create medicines that selectively silence the genes that cause disease using RNA interference, or RNAi. We are leaders in RNAi, harnessing the potential of this powerful and complex process to create medicines that can enhance the ...
-
Technologybased in South San Francisco, CALIFORNIA (USA)
At UNITY we are developing therapeutics to slow, halt, or reverse diseases of aging. Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial ...
Clinical Development Services
We are developing therapeutics that target senescence and adjacent biology with broad application across multiple indications with established endpoints and well-defined regulatory pathways to approval. Our initial focus is on delivering localized ...
CONTACT SUPPLIER -
Technologybased in Rye Brook, NEW YORK (USA)
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...
Schizophrenia Theraphy For Treatment
More than 1% of the US adult population is affected by schizophrenia, with symptoms falling into three categories: positive (hallucinations and delusions), negative (flat affect, difficulty in social interactions) and cognitive (complications with ...
CONTACT SUPPLIER -
Technologybased in Gwanak-ro, Gwanak-gu, SOUTH KOREA
KoBioLabs is recognized for its international level of technical skills by publishing a number of domestic and foreign patent papers in the fields of microbiome analysis, probiotics, and microbiome treatment technologies of various samples. In ...
KoBioLabs - Target Therapeutic Area Drug Pipeline
New Drug Development Focusing on Immune/Metabolic/Neurological. ...
CONTACT SUPPLIER -
Technologybased in Lynnwood, WASHINGTON (USA)
Kurve Therapeutics drug delivery technology is designed to target the most difficult part of the treatment process - getting medication through the blood-brain barrier and into the brain. Kurve Therapeutics has 18 peer-reviewed publications of ...
ViaNase - Treating Central Nervous System (CNS) Disorders
Researchers and scientists have spent the last 25 years trying and failing to develop effective treatments for brain diseases. The majority of the traditional treatments methods available can’t bypass the blood brain barrier, leaving the ...
CONTACT SUPPLIER -
Technologybased in Monterey, CALIFORNIA (USA)
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug Designation from the FDA for INT41 to treat Huntington’s disease a ...
Vybion - Model INT41 - Orphan Drug Designation
INT41 has received Orphan Drug Designation from the FDA for Huntington’s disease. IND enabling studies for INT41 Gene Therapy for Huntington’s disease are in place following a preIND meeting with the FDA in in February 2022 in response ...
CONTACT SUPPLIER -
Technologybased in Dublin, IRELAND
Neuromod Devices is a medical device company formed to advance the science of bimodal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and ...
Neuromod - Model Lenire - tinnitus Treatment Device
Neuromod has developed a tinnitus treatment device Lenire®, which is CE-marked for the treatment of tinnitus under the supervision of an appropriately qualified healthcare professional in Europe. The device comprises of three main ...
CONTACT SUPPLIER -
Technologybased in Eindhoven, NETHERLANDS
Our work builds on decades of research and translational science by giants in this important and emerging field. We were formed in 2014 by researchers at the Swiss Federal Institute of Technology (EPFL). We are now headquartered at the High Tech ...
ONWARD - ARC Therapy
We are working to enable people with spinal cord injury to move again, aided by ARC Therapy™ – targeted, programmed stimulation of the spinal cord. In addition to restoring movement, we have observed other potential benefits from spinal ...
CONTACT SUPPLIER -
Technologybased in Cambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
GW - Schizophrenia Treatment
Schizophrenia is a chronic disease that manifests through disturbances of perception, thought, cognition, emotion, motivation and motor activity. Over a lifetime, about 1% of the population will develop ...
CONTACT SUPPLIER -
Technologybased in Menlo Park, CALIFORNIA (USA)
Ionpath, Inc., is a pioneer in high-definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate medical discovery and improve human health. Ionpath’s MIBI (multiplexed ion beam imaging) platform breaks through the ...
Ionpath - Model 155Gd - CD11b [D6X1N] Antibody
Background:CD11b belongs to the integrin alpha chain family and is predominantly expressed on myeloid cell populations such as macrophages, monocytes, neutrophils and classical dendritic cells. CD11b expression can also be used to identify microglia ...
CONTACT SUPPLIER -
Technologybased in Kerrville, TEXAS (USA)
Vitanova Biomedical, Inc. (VNB) is a San Antonio, TX-based early stage biotechnology company developing patented (pending) technology licensed from the University of Texas at San Antonio. The company’s cancer treatment, Light-Activated Intracellular ...
-
Technologybased in Austin, TEXAS (USA)
BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s ...
Aortic Root Restoration Technology
Aortic valve repair is most frequently performed in cases of aortic insufficiency associated with aortic root aneurism. In cases of aortic root aneurism, dilation and distortion of the three dimensional aortic valve geometry can result in ...
CONTACT SUPPLIER -
Technologybased in Sacramento, CALIFORNIA (USA)
We are a next-generation biotechnology company creating an AI-powered platform for custom protein design. Our platform develops Novobinders: proprietary protein binders with diagnostic and therapeutic applications. AINovo Biotech works with select ...
-
Technologybased in Brooklyn, NEW YORK (USA)
Kaia was born when founders, Konstantin Mehl and Manuel Thurner, came together on their mission to find a more effective way to manage chronic back pain. After years of personal suffering from this issue, the founder duo discovered the solution: ...
-
Technologybased in Labège, FRANCE
Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases. Vaiomer challenges the frontiers of microbiome research by ...
Vaiomer - Bacterial Translocation Services
Bacterial translocation: the missing link between intestinal microbiome and human complex non-communicable diseases. Complex disorders are multifactorial and often chronic, caused by genetic and environmental factors and comprising hundreds of ...
CONTACT SUPPLIER -
Technologybased in Herzliya, ISRAEL
elminda was founded in 2006 with the goal of addressing the unmet needs of people suffering from brain related disorders. Our mission: perfect a technology that would reveal an individual’s unique brain function “signatures” or “fingerprints,” ...
CNS Drug Development Solutions
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease ...
CONTACT SUPPLIER -
Technologybased in Northbrook, ILLINOIS (USA)
ADMdx is a leader in the advanced use of imaging and other biomarkers to support the diagnosis and treatment of brain disorders. At ADMdx, we’re applying advances in image measurement and analysis to support earlier, more accurate identification ...
CorInsights - Model MRI - Advanced Reporting Tool
At ADMdx, we’re applying advances in image measurement and analysis to support earlier, more accurate identification of brain disorders including Alzheimer’s disease and other dementias. CorInsights MRI, our first FDA 510k cleared ...
CONTACT SUPPLIER -
Technologybased in Oxford, UNITED KINGDOM
Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM) technology uses MRI brain scan data to support ...
Cortical Disarray Measurement Technology
The challenge: Dementia - A Global Healthcare Crisis. Our breakthrough technology is helping us to rethink the way brain health is ...
CONTACT SUPPLIER -
Technologybased in Nes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
AstroRx - Functional Healthy Astrocytes
Clinical grade human astrocytes (the nervous system supporting cells) for the treatment of ALS and other neurodegenerative diseases. Received approval by the Israeli Ministry of Health to commence our phase I/IIa clinical trial in ALS patients. 6 ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you